Zomedica's Fourth Friday at Four Webinar Returns: Spotlight on the Assisi(R) Line - Advancing Drug-Free Healing for Pets
Zomedica (OTCQB:ZOMDF) announces its upcoming Fourth Friday at Four webinar on July 25, 2025, focusing on their Assisi product line of targeted Pulsed Electromagnetic Field (tPEMF) therapy devices. The webinar will showcase their drug-free solutions including the Assisi Loop®, Assisi Loop Lounge®, and Calmer Canine® products.
The session will feature insights into tPEMF technology, clinical outcomes, and real-world applications in veterinary care. Led by Nicole Westfall, Senior VP of Marketing, and Mialisa Gluckert, Senior Director of Assisi Commercialization, the webinar will demonstrate how these non-invasive treatments are revolutionizing pain and inflammation management in companion animals.
Zomedica (OTCQB:ZOMDF) annuncia il prossimo webinar Fourth Friday at Four, che si terrà il 25 luglio 2025 e sarà dedicato alla linea di prodotti Assisi, dispositivi di terapia a Campi Elettromagnetici Pulsati mirati (tPEMF). Il webinar presenterà le loro soluzioni senza farmaci, inclusi i prodotti Assisi Loop®, Assisi Loop Lounge® e Calmer Canine®.
La sessione offrirà approfondimenti sulla tecnologia tPEMF, sui risultati clinici e sulle applicazioni pratiche nella cura veterinaria. Guidato da Nicole Westfall, Vicepresidente Senior Marketing, e Mialisa Gluckert, Direttrice Senior della Commercializzazione Assisi, il webinar mostrerà come questi trattamenti non invasivi stiano rivoluzionando la gestione del dolore e dell'infiammazione negli animali da compagnia.
Zomedica (OTCQB:ZOMDF) anuncia su próximo seminario web Fourth Friday at Four, que se realizará el 25 de julio de 2025, centrado en su línea de productos Assisi, dispositivos de terapia con Campos Electromagnéticos Pulsados dirigidos (tPEMF). El seminario presentará sus soluciones libres de medicamentos, incluyendo los productos Assisi Loop®, Assisi Loop Lounge® y Calmer Canine®.
La sesión ofrecerá perspectivas sobre la tecnología tPEMF, resultados clínicos y aplicaciones en el mundo real en el cuidado veterinario. Liderado por Nicole Westfall, Vicepresidenta Senior de Marketing, y Mialisa Gluckert, Directora Senior de Comercialización de Assisi, el seminario demostrará cómo estos tratamientos no invasivos están revolucionando el manejo del dolor y la inflamación en animales de compañía.
Zomedica (OTCQB:ZOMDF)는 2025년 7월 25일에 열리는 Fourth Friday at Four 웨비나를 발표하며, 타겟 펄스 전자기장(tPEMF) 치료 기기인 Assisi 제품군에 초점을 맞춥니다. 이 웨비나에서는 Assisi Loop®, Assisi Loop Lounge®, Calmer Canine® 등 약물 없이 사용하는 솔루션을 선보일 예정입니다.
세션에서는 tPEMF 기술, 임상 결과, 수의학 분야에서의 실제 적용 사례를 다룹니다. 마케팅 수석 부사장 Nicole Westfall와 Assisi 상업화 수석 이사 Mialisa Gluckert가 이끄는 이번 웨비나는 비침습적 치료법이 반려동물의 통증 및 염증 관리에 어떻게 혁신을 가져오는지 보여줄 것입니다.
Zomedica (OTCQB:ZOMDF) annonce son prochain webinaire Fourth Friday at Four qui aura lieu le 25 juillet 2025, mettant en avant leur gamme de produits Assisi, des dispositifs de thérapie par champ électromagnétique pulsé ciblé (tPEMF). Le webinaire présentera leurs solutions sans médicament, incluant les produits Assisi Loop®, Assisi Loop Lounge® et Calmer Canine®.
Cette session offrira des perspectives sur la technologie tPEMF, les résultats cliniques et les applications concrètes en soins vétérinaires. Animé par Nicole Westfall, Vice-Présidente Senior Marketing, et Mialisa Gluckert, Directrice Senior de la commercialisation Assisi, le webinaire démontrera comment ces traitements non invasifs révolutionnent la gestion de la douleur et de l'inflammation chez les animaux de compagnie.
Zomedica (OTCQB:ZOMDF) kündigt sein bevorstehendes Fourth Friday at Four Webinar am 25. Juli 2025 an, das sich auf die Assisi-Produktlinie von zielgerichteten gepulsten elektromagnetischen Feldtherapie-Geräten (tPEMF) konzentriert. Das Webinar stellt ihre medikamentenfreien Lösungen vor, darunter die Produkte Assisi Loop®, Assisi Loop Lounge® und Calmer Canine®.
Die Sitzung bietet Einblicke in die tPEMF-Technologie, klinische Ergebnisse und praktische Anwendungen in der veterinärmedizinischen Versorgung. Geleitet von Nicole Westfall, Senior VP Marketing, und Mialisa Gluckert, Senior Director der Assisi-Kommerzialisierung, zeigt das Webinar, wie diese nicht-invasiven Behandlungen die Schmerz- und Entzündungsbehandlung bei Begleittieren revolutionieren.
- None.
- None.
Breakthrough tPEMF™ Technology Showcased in Monthly Series Exploring Innovation in Veterinary Care
ANN ARBOR, MI / ACCESS Newswire / July 16, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), a veterinary health company offering advanced diagnostic and therapeutic solutions for companion and equine animals, is pleased to announce the next installment of its Fourth Friday at Four webinar series, scheduled for Friday, July 25, 2025 at 4:00 PM ET.
This month's session will highlight the Assisi line of products, Zomedica's suite of targeted Pulsed Electromagnetic Field (tPEMF) therapy devices that offer non-invasive, drug-free solutions for managing pain and inflammation in companion animals. Designed for both in-clinic and at-home use, the Assisi Loop®, Assisi Loop Lounge®, and Calmer Canine® products have become trusted tools for veterinarians and pet parents alike.
What to Expect:
A closer look at the science behind tPEMF therapy
Real-world success stories and clinical outcomes
How veterinarians are integrating Assisi products into daily care
Interactive Q&A with the Assisi and Zomedica teams
"Our Assisi Loop line of products represents the perfect blend of science, compassion, and innovation," said Nicole Westfall, Senior Vice President of Marketing at Zomedica. "We're excited to highlight how tPEMF therapy is helping animals heal faster, feel better, and live more comfortably-without relying on pharmaceuticals."
Mialisa Gluckert, Senior Director of Assisi Commercialization, added, "This month's webinar will offer an insider's perspective on how our customers are using Assisi products every day to support recovery, ease chronic conditions, and transform outcomes across veterinary practices. It's inspiring to see how far we've come-and where we're going next."
Whether you're a veterinary professional, industry partner, investor, or simply passionate about pet wellness, this webinar will provide valuable insights into the clinical, commercial, and compassionate impact of Assisi drug-free healing technology.
Webinar Registration & Details
Connect, Learn, and Discover What's Next in Veterinary Innovation
Don't miss your chance to connect with industry experts, get a firsthand look at groundbreaking veterinary technologies, and explore what's next in animal healthcare. Whether you're a veterinary professional, industry partner, investor, or simply passionate about helping our pets live healthier lives-this series is for you.
Reserve your spot for the next session by clicking the link below:
Zomedica 4th Friday at Four Registration
Or head to: www.investors.zomedica.com
About Zomedica
Zomedica is a leading equine and companion animal healthcare company dedicated to improving animal health by providing veterinarians innovative therapeutic and diagnostic solutions. Our gold standard PulseVet® shock wave system, which accelerates healing in musculoskeletal conditions, has transformed veterinary therapeutics. Our suite of products also includes the Assisi® Loop line of therapeutic devices and the TRUFORMA® diagnostic platform, the TRUVIEW® digital cytology system, and the VetGuardian® no-touch monitoring system, all designed to empower veterinarians to provide top-tier care. In the aggregate, their total addressable market in the U.S. exceeds
Follow Zomedica
Cautionary Note Regarding Forward-Looking Statements
Except for statements of historical fact, this news release contains certain "forward-looking information" or "forward-looking statements" (collectively, "forward-looking information") within the meaning of applicable securities law. Forward-looking information is frequently characterized by words such as "plan", "expect", "project", "intend", "believe", "anticipate", "estimate" and other similar words, or statements that certain events or conditions "may" or "will" occur and include statements relating to our expectations regarding future results. Although we believe that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct. We cannot guarantee future results, performance, or achievements. Consequently, there is no representation that the actual results achieved will be the same, in whole or in part, as those set out in the forward-looking information.
Forward-looking information is based on the opinions and estimates of management at the date the statements are made, including assumptions with respect to economic growth, demand for the Company's products, the Company's ability to produce and sell its products, sufficiency of our budgeted capital and operating expenditures, the satisfaction by our strategic partners of their obligations under our commercial agreements and our ability to realize upon our business plans and cost control efforts.
Our forward-looking information is subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those anticipated in the forward-looking information. Some of the risks and other factors that could cause the results to differ materially from those expressed in the forward-looking information include, but are not limited to: the outcome of clinical studies, the application of generally accepted accounting principles, which are highly complex and involve many subjective assumptions, estimates, and judgments, uncertainty as to whether our strategies and business plans will yield the expected benefits; uncertainty as to the timing and results of development work and verification and validation studies; uncertainty as to the timing and results of commercialization efforts, including international efforts, as well as the cost of commercialization efforts, including the cost to develop an internal sales force and manage our growth; uncertainty as to our ability to realize the anticipated growth opportunities from our acquisitions; uncertainty as to our ability to supply products in response to customer demand; supply chain risks associated with tariff changes; uncertainty as to the likelihood and timing of any required regulatory approvals, and the availability and cost of capital; the ability to identify and develop and achieve commercial success for new products and technologies; veterinary acceptance of our products and purchase of consumables following adoption of our capital equipment; competition from related products; the level of expenditures necessary to maintain and improve the quality of products and services; changes in technology and changes in laws and regulations; our ability to secure and maintain strategic relationships; performance by our strategic partners of their obligations under our commercial agreements, including product manufacturing obligations; risks pertaining to permits and licensing, intellectual property infringement risks, risks relating to any required clinical trials and regulatory approvals, risks relating to the safety and efficacy of our products, the use of our products, intellectual property protection, and the other risk factors disclosed in our filings with the SEC and under our profile on SEDAR+ at www.sedarplus.com. Readers are cautioned that this list of risk factors should not be construed as exhaustive.
The forward-looking information contained in this news release is expressly qualified by this cautionary statement. We undertake no duty to update any of the forward-looking information to conform such information to actual results or to changes in our expectations except as otherwise required by applicable securities legislation. Readers are cautioned not to place undue reliance on forward-looking information.
Investor Relations Contact:
Zomedica Investor Relations
investors@zomedica.com
1-734-369-2555
SOURCE: Zomedica Corp.
View the original press release on ACCESS Newswire
FAQ
When is Zomedica's (ZOMDF) next Fourth Friday at Four webinar scheduled?
What products will be featured in Zomedica's July 2025 webinar?
What is the purpose of Zomedica's Assisi product line?
How can investors register for Zomedica's Fourth Friday at Four webinar?
Who are the key speakers at Zomedica's July 2025 webinar?
